CGEM
Price
$7.87
Change
-$0.29 (-3.55%)
Updated
Jun 20, 11:27 AM (EDT)
Capitalization
481.56M
48 days until earnings call
GOSS
Price
$1.33
Change
+$0.05 (+3.88%)
Updated
Jun 20, 02:44 PM (EDT)
Capitalization
293.22M
53 days until earnings call
Interact to see
Advertisement

CGEM vs GOSS

Header iconCGEM vs GOSS Comparison
Open Charts CGEM vs GOSSBanner chart's image
Cullinan Therapeutics
Price$7.87
Change-$0.29 (-3.55%)
Volume$200
Capitalization481.56M
Gossamer Bio
Price$1.33
Change+$0.05 (+3.88%)
Volume$200
Capitalization293.22M
CGEM vs GOSS Comparison Chart in %
Loading...
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEM vs. GOSS commentary
Jun 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a Hold and GOSS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 20, 2025
Stock price -- (CGEM: $8.16 vs. GOSS: $1.29)
Brand notoriety: CGEM and GOSS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 83% vs. GOSS: 47%
Market capitalization -- CGEM: $481.56M vs. GOSS: $293.22M
CGEM [@Biotechnology] is valued at $481.56M. GOSS’s [@Biotechnology] market capitalization is $293.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $335.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whileGOSS’s FA Score has 0 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • GOSS’s FA Score: 0 green, 5 red.
According to our system of comparison, CGEM is a better buy in the long-term than GOSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 6 TA indicator(s) are bullish while GOSS’s TA Score has 4 bullish TA indicator(s).

  • CGEM’s TA Score: 6 bullish, 4 bearish.
  • GOSS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CGEM is a better buy in the short-term than GOSS.

Price Growth

CGEM (@Biotechnology) experienced а -9.13% price change this week, while GOSS (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.33%. For the same industry, the average monthly price growth was +31.28%, and the average quarterly price growth was +16.86%.

Reported Earning Dates

CGEM is expected to report earnings on Aug 07, 2025.

GOSS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+11.33% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGEM($482M) has a higher market cap than GOSS($293M). GOSS YTD gains are higher at: 42.604 vs. CGEM (-33.005). GOSS has higher annual earnings (EBITDA): -35.7M vs. CGEM (-208.62M). CGEM has more cash in the bank: 304M vs. GOSS (258M). CGEM has less debt than GOSS: CGEM (1.84M) vs GOSS (203M). GOSS has higher revenues than CGEM: GOSS (125M) vs CGEM (0).
CGEMGOSSCGEM / GOSS
Capitalization482M293M165%
EBITDA-208.62M-35.7M584%
Gain YTD-33.00542.604-77%
P/E RatioN/AN/A-
Revenue0125M-
Total Cash304M258M118%
Total Debt1.84M203M1%
FUNDAMENTALS RATINGS
GOSS: Fundamental Ratings
GOSS
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGEMGOSS
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 17 days ago
73%
Bullish Trend 17 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PCCGX10.910.05
+0.46%
Victory Pioneer Mid Cap Value C
NOMIX20.190.06
+0.30%
Northern Mid Cap Index
NIECX17.700.02
+0.11%
BNY Mellon International Equity C
TMCGX14.630.01
+0.07%
Thrivent Mid Cap Growth S
VIAAX43.16-0.01
-0.02%
Vanguard Intl Div Apprec Idx Adm

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with MDGL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
-1.92%
MDGL - CGEM
50%
Loosely correlated
+1.12%
DNLI - CGEM
47%
Loosely correlated
-3.63%
FATE - CGEM
46%
Loosely correlated
+0.83%
BEAM - CGEM
46%
Loosely correlated
+1.92%
IDYA - CGEM
45%
Loosely correlated
-0.27%
More